Global GMPs: How Much Faith Will U.S. FDA Put In Private Third-Party Audits?
This article was originally published in PharmAsia News
Executive Summary
Private and third-party audits may not replace U.S. FDA's typical inspection duties, but could help direct the agency to problematic facilities and relieve some of the inspection burden on those that already are compliant